Association of Time to Kidney Transplantation With Graft Failure Among US Patients With End-Stage Renal Disease Due to Lupus Nephritis

被引:36
|
作者
Plantinga, Laura C. [1 ,2 ]
Patzer, Rachel E. [3 ,4 ]
Drenkard, Cristina [4 ]
Kramer, Michael R. [1 ]
Klein, Mitchel [1 ]
Lim, S. Sam [4 ]
McClellan, William M. [1 ]
Pastan, Stephen O. [3 ,4 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA
[3] Emory Healthcare, Emory Transplant Ctr, Atlanta, GA USA
[4] Emory Univ, Sch Med, Atlanta, GA 30322 USA
关键词
HEALTH DISPARITIES; OUTCOMES; RECIPIENTS; MORTALITY; DIALYSIS; ACCESS; GUIDELINES;
D O I
10.1002/acr.22482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveProviders recommend waiting to transplant patients with end-stage renal disease (ESRD) secondary to lupus nephritis (LN), to allow for quiescence of systemic lupus erythematosus (SLE)-related immune activity. However, these recommendations are not standardized, and we sought to examine whether duration of time to transplant was associated with risk of graft failure in US LN-ESRD patients. MethodsUsing national ESRD surveillance data (United States Renal Data System), we identified 4,743 US patients with LN-ESRD who received a first transplant on or after January 1, 2000 (followup through September 30, 2011). The association of wait time (time from ESRD start to transplant) with graft failure was assessed with Cox proportional hazards models, with splines of the exposure to allow for nonlinearity of the association and with adjustment for potential confounding by demographic, clinical, and transplant factors. ResultsWhite LN-ESRD patients who were transplanted later (versus at <3 months receiving dialysis) were at increased risk of graft failure (3-12 months: adjusted hazard ratio [HR] 1.23, 95% confidence interval [95% CI] 0.93-1.63; 12-24 months: adjusted HR 1.37, 95% CI 0.92-2.06; 24-36 months: adjusted HR 1.34, 95% CI 0.92-1.97; and >36 months: adjusted HR 1.98, 95% CI 1.31-2.99). However, no such association was seen among African American recipients (3-12 months: adjusted HR 1.07, 95% CI 0.79-1.45; 12-24 months: adjusted HR 1.01, 95% CI 0.64-1.60; 24-36 months: adjusted HR 0.78, 95% CI 0.51-1.18; and >36 months: adjusted HR 0.74, 95% CI 0.48-1.13). ConclusionWhile future studies are needed to examine the potential confounding effect of clinically recognized SLE activity on the observed associations, these results suggest that longer wait times to transplant may be associated with equivalent or worse, not better, graft outcomes among LN-ESRD patients.
引用
收藏
页码:571 / 581
页数:11
相关论文
共 50 条
  • [41] Burden of end-stage renal disease and evolving challenges in kidney transplantation
    Golshayan, Dela
    Pascual, Manuel
    TRANSPLANT INTERNATIONAL, 2019, 32 (09) : 889 - 891
  • [42] Frailty and mortality among patients with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis
    Zhang, Quanchao
    Ma, Yingying
    Lin, Faying
    Zhao, Jinghong
    Xiong, Jiachuan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (02) : 363 - 370
  • [43] Impact of end-stage renal disease and kidney transplantation on the reproductive system
    Delesalle, A. -S.
    Robin, G.
    Provot, F.
    Dewailly, D.
    Leroy-Billiard, M.
    Peigne, M.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2015, 43 (01): : 33 - 40
  • [44] Psychiatric diagnoses in patients with renal transplantation or dialysis made due to end stage renal disease
    Akgul Ceyhun, Hacer
    Kirpinar, Ismet
    ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2019, 20 (04): : 426 - 435
  • [45] Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease
    Thorp, Micah L.
    Johnson, Eric S.
    Yang, Xuihai
    Petrik, Amanda F.
    Platt, Robert
    Smith, David H.
    NEPHROLOGY, 2009, 14 (02) : 240 - 246
  • [46] Age and Association of Kidney Measures With Mortality and End-stage Renal Disease
    Hallan, Stein I.
    Matsushita, Kunihiro
    Sang, Yingying
    Mahmoodi, Bakhtawar K.
    Black, Corri
    Ishani, Areef
    Kleefstra, Nanne
    Naimark, David
    Roderick, Paul
    Tonelli, Marcello
    Wetzels, Jack F. M.
    Astor, Brad C.
    Gansevoort, Ron T.
    Levin, Adeera
    Wen, Chi-Pang
    Coresh, Josef
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (22): : 2349 - 2360
  • [47] Association of Pulmonary Hypertension With End-Stage Renal Disease Among the Obese Population
    Jameel, Farah Anum
    Junejo, Abdul Mannan
    Ejaz, Ayesha
    Khan, Qurat ul Ain
    Bhopal, Kamran Faisal
    Faraz, Ahmad
    Rizvi, Syed Hasan Mustafa
    Ahmad, Fatima
    Tahir, Muhammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [48] Effectiveness of Preceding Solo Kidney Transplantation for Type 1 Diabetes With End-Stage Renal Failure
    Ito, T.
    Kenmochi, T.
    Aida, N.
    Kurihara, K.
    Kawai, A.
    Ito, T.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 3249 - 3254
  • [49] Extent and Severity of Coronary Disease and Mortality in Patients with End-Stage Renal Failure Evaluated for Renal Transplantation
    Jones, D. G.
    Taylor, A. M.
    Enkiri, S. A.
    Lobo, P.
    Brayman, K. L.
    Keeley, E. C.
    Lipson, L. C.
    Gimple, L. W.
    Ragosta, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (08) : 1846 - 1852
  • [50] Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation
    Cheng, Xingxing S.
    Stedman, Margaret R.
    Chertow, Glenn M.
    Kim, W. Ray
    Tan, Jane C.
    TRANSPLANTATION, 2017, 101 (05) : 1111 - 1119